{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:06:55Z","timestamp":1784066815248,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.heliyon.2024.e35789","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T02:53:56Z","timestamp":1722653636000},"page":"e35789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Differential effect of asparagine and glutamine removal on three adenocarcinoma cell lines"],"prefix":"10.1016","volume":"10","author":[{"given":"Greta","family":"Pessino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Lonati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Cazzalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Iaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Previtali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Baiocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Perucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tricarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Vetro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Anna","family":"Stivala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ganini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cancelliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Zucchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Guardamagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9075-8143","authenticated-orcid":false,"given":"Maristella","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e35789_bib1","doi-asserted-by":"crossref","first-page":"19952","DOI":"10.1074\/jbc.R117.819060","article-title":"Asparagine synthetase: function, structure, and role in disease","volume":"292","author":"Lomelino","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e35789_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physiolgenomics.00217.2009","article-title":"Expression profiling after activation of amino acid deprivation response in HepG2 human hepatoma cells","volume":"41","author":"Shan","year":"2010","journal-title":"Physiol. Genomics."},{"key":"10.1016\/j.heliyon.2024.e35789_bib3","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00015.2013","article-title":"Asparagine synthetase: regulation by cell stress and involvement in tumor biology","volume":"304","author":"Balasubramanian","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2024.e35789_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molcel.2014.08.018","article-title":"Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion","volume":"56","author":"Zhang","year":"2014","journal-title":"Mol. Cell."},{"key":"10.1016\/j.heliyon.2024.e35789_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2017.12.006","article-title":"As extracellular glutamine levels decline, asparagine becomes an essential amino acid","volume":"27","author":"Pavlova","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.heliyon.2024.e35789_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11457","article-title":"Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor","volume":"7","author":"Krall","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e35789_bib7","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051436","article-title":"MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction","volume":"22","author":"Pathria","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.heliyon.2024.e35789_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2018.00212","article-title":"Development of L-asparaginase biobetters: current research status and review of the desirable quality profiles","volume":"6","author":"Brumano","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e35789_bib9","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1182\/blood-2013-10-535112","article-title":"The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells","volume":"123","author":"Chan","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e35789_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.124.3212.124","article-title":"Dual requirement of Walker carcinosarcoma 256 in vitro for asparagine and glutamine","volume":"124","author":"Neuman","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e35789_bib11","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1200\/JCO.2005.11.411","article-title":"Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia","volume":"23","author":"Pession","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e35789_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molmet.2019.11.011","article-title":"Targeting extracellular nutrient dependencies of cancer cells","volume":"33","author":"Garcia-Bermudez","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.heliyon.2024.e35789_bib13","first-page":"257","article-title":"Mechanism of action of l-asparaginase on the cell cycle and growth acute lymphoblastic leukemia","volume":"50","author":"Pagliardi","year":"1973","journal-title":"Acta Haematol."},{"key":"10.1016\/j.heliyon.2024.e35789_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00000658-199312000-00004","article-title":"Glutamine and cancer","volume":"218","author":"Souba","year":"1993","journal-title":"Ann. Surg."},{"key":"10.1016\/j.heliyon.2024.e35789_bib15","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood-2010-07-298422","article-title":"Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity","volume":"117","author":"Offman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e35789_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/157489212798358001","article-title":"Expanding targets for a metabolic therapy of cancer: L-asparaginase, Recent Pat","volume":"7","author":"Covini","year":"2012","journal-title":"Anticancer. Drug Discov."},{"key":"10.1016\/j.heliyon.2024.e35789_bib17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.beha.2008.08.004","article-title":"Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?","volume":"21","author":"Douer","year":"2008","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.heliyon.2024.e35789_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2019.10.020","article-title":"Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: an open-label, randomized Phase IIb trial","volume":"124","author":"Hammel","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e35789_bib19","unstructured":"Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer - Full Text View - ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05034627 (accessed April 11, 2023)."},{"key":"10.1016\/j.heliyon.2024.e35789_bib20","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.bbrc.2018.06.167","article-title":"l-asparaginase induces intrinsic mitochondrial-mediated apoptosis in human gastric adenocarcinoma cells and impedes tumor progression","volume":"503","author":"Sindhu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2024.e35789_bib21","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1111\/j.1582-4934.2012.01547.x","article-title":"L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer","volume":"16","author":"Yu","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e35789_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature25465","article-title":"Asparagine bioavailability governs metastasis in a model of breast cancer","volume":"554","author":"Knott","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e35789_bib23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1672-7","article-title":"The landscape of somatic mutation in normal colorectal epithelial cells","volume":"574","author":"Lee-Six","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e35789_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15075-4","article-title":"A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro","volume":"7","author":"Maggi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e35789_bib25","first-page":"24","article-title":"A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia","volume":"91","author":"Rizzari","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.heliyon.2024.e35789_bib26","first-page":"4554","article-title":"L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans","volume":"41","author":"Riccardi","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e35789_bib27","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0959-8049(96)00131-1","article-title":"Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations","volume":"32A","author":"Boos","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e35789_bib28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.leukres.2015.04.008","article-title":"Glutaminase activity determines cytotoxicity of l-asparaginases on most leukemia cell lines","volume":"39","author":"Parmentier","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.heliyon.2024.e35789_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-015-0618-9","article-title":"Discrimination of cell cycle phases in PCNA-immunolabeled cells","volume":"16","author":"Sch\u00f6nenberger","year":"2015","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.heliyon.2024.e35789_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.heliyon.2024.e35789_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2013.85","article-title":"Cancer cell metabolism: implications for therapeutic targets","volume":"45","author":"Jang","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e35789_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710037","article-title":"Revisited metabolic control and reprogramming cancers by means of the warburg effect in tumor cells","volume":"23","author":"Fukushi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e35789_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e35789_bib34","article-title":"Targeting nutrient dependency in cancer treatment","volume":"12","author":"Fan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e35789_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-981-13-7709-9_9","article-title":"Enzymes in metabolic anticancer therapy","volume":"1148","author":"Maggi","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.heliyon.2024.e35789_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.leukres.2015.04.008","article-title":"Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines","volume":"39","author":"Parmentier","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.heliyon.2024.e35789_bib37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/pbc.21213","article-title":"Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines","volume":"50","author":"Su","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.heliyon.2024.e35789_bib38","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1158\/1535-7163.MCT-18-1329","article-title":"Glutaminase activity of L-asparaginase contributes to durable preclinical activity against acute lymphoblastic leukemia","volume":"18","author":"Chan","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.heliyon.2024.e35789_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11060402","article-title":"Asparagine: a metabolite to Be targeted in cancers","volume":"11","author":"Jiang","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.heliyon.2024.e35789_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032983","article-title":"Asparagine and glutamine deprivation alters ionizing radiation response, migration and adhesion of a p53null colorectal cancer cell line","volume":"24","author":"Guardamagna","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e35789_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv073","article-title":"MCF-7 cells--changing the course of breast cancer research and care for 45 years","volume":"107","author":"Lee","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.heliyon.2024.e35789_bib42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0039-128X(75)90110-5","article-title":"MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors","volume":"26","author":"Horwitz","year":"1975","journal-title":"Steroids"},{"key":"10.1016\/j.heliyon.2024.e35789_bib43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/BF02617972","article-title":"In vitro cultivation of human renal cell cancer. II. Characterization of cell lines","volume":"14","author":"Willia","year":"1978","journal-title":"In Vitro"},{"key":"10.1016\/j.heliyon.2024.e35789_bib44","article-title":"Choosing the right animal model for renal cancer research, transl","volume":"13","author":"Sobczuk","year":"2020","journal-title":"Oncol."},{"key":"10.1016\/j.heliyon.2024.e35789_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbcan.2018.06.003","article-title":"Genetic and metabolic hallmarks of clear cell renal cell carcinoma","volume":"1870","author":"Sanchez","year":"2018","journal-title":"Biochim. Biophys. Acta. Rev. Cancer."},{"key":"10.1016\/j.heliyon.2024.e35789_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214360","article-title":"Renal cell carcinoma as a metabolic disease: an update on main pathways, potential biomarkers, and therapeutic targets","volume":"23","author":"di Meo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e35789_bib47","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/excr.1998.4172","article-title":"Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism","volume":"243","author":"Foster","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.heliyon.2024.e35789_bib48","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.18632\/oncotarget.2869","article-title":"Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells","volume":"6","author":"Song","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2024.e35789_bib49","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1038\/sj.emboj.7601432","article-title":"Structural mechanism of RPA loading on DNA during activation of a simple pre-replication complex","volume":"25","author":"Jiang","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2024.e35789_bib50","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/aob\/mcq243","article-title":"Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation","volume":"107","author":"Strzalka","year":"2011","journal-title":"Ann. Bot."},{"key":"10.1016\/j.heliyon.2024.e35789_bib51","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846263","article-title":"Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments","volume":"19","author":"Liao","year":"2018","journal-title":"EMBO Rep."},{"issue":"2021","key":"10.1016\/j.heliyon.2024.e35789_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-03229-8","article-title":"Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway","volume":"12","author":"Xie","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e35789_bib53","first-page":"1","article-title":"Glutamine synthetase as a therapeutic target for cancer treatment","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e35789_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176156","article-title":"A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells","volume":"960","author":"Pan","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e35789_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2020.01.035","article-title":"Suppression of asparagine synthetase enhances the antitumor potency of ART and artemalogue SOMCL-14-221 in non-small cell lung cancer","volume":"475","author":"Xiao","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.heliyon.2024.e35789_bib56","doi-asserted-by":"crossref","first-page":"9145","DOI":"10.1007\/s00253-016-7640-3","article-title":"Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy","volume":"100","author":"Zhang","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e35789_bib57","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cmet.2021.02.001","article-title":"Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth","volume":"33","author":"Krall","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.heliyon.2024.e35789_bib58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0065-2571(81)90017-0","article-title":"Kinetic, physical, and regulatory properties of amidophosphoribosyltransferase","volume":"19","author":"Holmes","year":"1980","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.heliyon.2024.e35789_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm7902","article-title":"Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms","volume":"8","author":"Cappello","year":"2022","journal-title":"Sci. Adv."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024118208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024118208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:01:36Z","timestamp":1784066496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024118208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":59,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2405844024118208"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35789","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effect of asparagine and glutamine removal on three adenocarcinoma cell lines","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e35789"}}